SCHEMBL28106576

SCHEMBL28106576

CC(C)(C)C(=O)OCC1(CN=[N+]=[N-])CCNC1

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28067866 0.76
SCHEMBL27783464 0.76 PRKCA (0.38) PRKCA
SCHEMBL18165027 0.75
SCHEMBL17032257 0.73
SCHEMBL17032263 0.73
Tert-Butyl Formate SCHEMBL28106577 0.72 TDP1 (0.32)
SCHEMBL28000343 0.72 SMN1; SMN2 (0.33) PRKCA
Tert-Butyl Formate SCHEMBL28106575 0.71
SCHEMBL28680025 0.69 PRKCA (0.33) PRKCA
SCHEMBL28114836 0.69 PRKCA (0.32) PRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106103445-B The therapeutical uses of pyrazolo [1,5-A] pyrimidine -5,7- diamine compound and they as CDK inhibitor 癌症研究技术有限公司 2019-08-09 CN disclosed
CN-106103445-A Pyrazolo [1,5 A] pyrimidine 5,7 diamine compound and their therapeutic use as CDK inhibitor 癌症研究技术有限公司 2016-11-09 CN disclosed